A revolutionary treatment that improves the quality of life for Parkinson’s patients
DUODOPA® is a levodopa-carbidopa combination allowing to treat Parkinson’s disease at a late stage. A unique delivery system, with a programmable pump, allows both the physician and the patient to individually fine-tune the delivery of active ingredients suspended in a stable gel, from a cassette worn outside the body.
Parkinson’s affects both men and women and, among the neurodegenerative disorders, is second only to Alzheimer’s disease in the number of cases, with more than 1.3 million patients suffering from it in each of most major countries.
